Synopsis
Synopsis
0
EU WC
0
KDMF
0
VMF
0
Europe
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Arginine
2. Arginine, L Isomer
3. Arginine, L-isomer
4. Dl Arginine Acetate, Monohydrate
5. Dl-arginine Acetate, Monohydrate
6. Hydrochloride, Arginine
7. L Arginine
8. L-arginine
9. L-isomer Arginine
10. Monohydrate Dl-arginine Acetate
1. L-arginine Hydrochloride
2. 1119-34-2
3. L-arginine Monohydrochloride
4. L-arginine Hcl
5. H-arg-oh.hcl
6. Arginine Hcl
7. 15595-35-4
8. L-arginine, Monohydrochloride
9. Levargin
10. Arginine Monohydrochloride
11. Argamine
12. Argivene
13. Detoxargin
14. L-(+)-arginine Monohydrochloride
15. Minophagen A
16. (s)-2-amino-5-guanidinopentanoic Acid Hydrochloride
17. R-gene 10
18. R-gene
19. L-arginine (hydrochloride)
20. L-(+)-arginine Hydrochloride
21. (s)-(+)-arginine Hydrochloride
22. Arginine Monochloride
23. F7lth1e20y
24. L-arginine, Hydrochloride (1:1)
25. Mfcd00064550
26. Nsc-7914
27. Nsc-203450
28. L(+)-arginine Hydrochloride
29. (+)-l-arginine Hydrochloride
30. (2s)-2-amino-5-carbamimidamidopentanoic Acid Hydrochloride
31. L-arginine, Hydrochloride
32. Tivortin
33. R-gene (tn)
34. Arginine, Hydrochloride, L-
35. L-arginine Hydrochloride (van)
36. Arginine Hydrochloride [usan:jan]
37. Nsc 7914
38. Einecs 214-275-1
39. Unii-f7lth1e20y
40. Nsc 203450
41. (2s)-2-amino-5-carbamimidamidopentanoic Acid;hydrochloride
42. (2s)-2-amino-5-(diaminomethylideneamino)pentanoic Acid;hydrochloride
43. Ai3-18300
44. H-arg-oh?cl
45. L-argininexhydrochloride
46. L-arginine Xhydrochloride
47. L- Arginine Hydrochloride
48. L-arginine Monochlorhydrate
49. Ec 214-275-1
50. L-arginine Hcl (l-arg)
51. Argininine Monohydrocholoride
52. Arginine Hcl [inci]
53. Schembl44977
54. Arginine Hydrochloride (usp)
55. Chembl1200381
56. Chebi:31235
57. Hy-n0455a
58. L-arginine Hydrochloride Solution
59. Dtxsid20883650
60. L-arginine Hydrochloride (jp17)
61. Arginine Hydrochloride [mi]
62. L-arginine, Monohydrochloride, L-
63. Arginine, L-, Hydrochloride
64. Arginine Hydrochloride [usan]
65. Ccg-43265
66. S3174
67. Arginine Hydrochloride [vandf]
68. (s)-(+)-2-amino-5-[(aminoiminomethyl)amino]pentanoic Acid Monohydrochloride
69. Akos015906195
70. Akos015924214
71. Arginine Hydrochloride [mart.]
72. L-arginine Hydrochloride [jan]
73. Am81503
74. Arginine Hydrochloride [usp-rs]
75. Arginine Hydrochloride [who-dd]
76. Cs-2046
77. Ds-2054
78. Ac-23975
79. L-arginine Monohydrochloride [fcc]
80. Arginine Hydrochloride [orange Book]
81. Db-029943
82. A0528
83. A7080
84. Arginine Hydrochloride [ep Monograph]
85. Cs-0368604
86. Arginine Hydrochloride [usp Monograph]
87. A-8580
88. D01126
89. D70773
90. 119a342
91. A802447
92. Arginine Hydrochloride (l-arginine Hydrochloride)
93. L-arginine Monohydrochloride, Vetec(tm), 98.5%
94. J-521633
95. Sr-01000075479-3
96. Q27277776
97. L-arginine Hydrochloride, Saj Special Grade, >=99.0%
98. L-arginine Monohydrochloride, Bioultra, >=99.5% (at)
99. L-arginine Monohydrochloride, Vetec(tm) Reagent Grade, >=98%
100. L-arginine Monohydrochloride, Reagent Grade, >=98% (hplc), Powder
101. Arginine Hydrochloride, British Pharmacopoeia (bp) Reference Standard
102. Arginine Hydrochloride, European Pharmacopoeia (ep) Reference Standard
103. L-arginine Monohydrochloride, Certified Reference Material, Tracecert(r)
104. Arginine Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
105. L-arginine Hydrochloride Solution, 100 Mm Amino Acid In 0.1 M Hcl, Analytical Standard
106. L-arginine Monohydrochloride, Not Synthetic, Meets Ep, Jp, Usp Testing Specifications, Suitable For Cell Culture, 98.5-101.0%
107. L-arginine Monohydrochloride, Pharmagrade, Ajinomoto, Ep, Jp, Usp, Manufactured Under Appropriate Gmp Controls For Pharma Or Biopharmaceutical Production, Suitable For Cell Culture
Molecular Weight | 210.66 g/mol |
---|---|
Molecular Formula | C6H15ClN4O2 |
Hydrogen Bond Donor Count | 5 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 5 |
Exact Mass | 210.0883534 g/mol |
Monoisotopic Mass | 210.0883534 g/mol |
Topological Polar Surface Area | 128 Ų |
Heavy Atom Count | 13 |
Formal Charge | 0 |
Complexity | 176 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | R-gene 10 |
Active Ingredient | Arginine hydrochloride |
Dosage Form | Injectable |
Route | Injection |
Strength | 10gm/100ml |
Market Status | Prescription |
Company | Pharmacia And Upjohn |
2 of 2 | |
---|---|
Drug Name | R-gene 10 |
Active Ingredient | Arginine hydrochloride |
Dosage Form | Injectable |
Route | Injection |
Strength | 10gm/100ml |
Market Status | Prescription |
Company | Pharmacia And Upjohn |
B - Blood and blood forming organs
B05 - Blood substitutes and perfusion solutions
B05X - I.v. solution additives
B05XB - Amino acids
B05XB01 - Arginine hydrochloride
Related Excipient Companies
Excipients by Applications
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
66
PharmaCompass offers a list of L-Arginine Hydrochloride API API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right L-Arginine Hydrochloride API manufacturer or L-Arginine Hydrochloride API supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred L-Arginine Hydrochloride API manufacturer or L-Arginine Hydrochloride API supplier.
PharmaCompass also assists you with knowing the L-Arginine Hydrochloride API API Price utilized in the formulation of products. L-Arginine Hydrochloride API API Price is not always fixed or binding as the L-Arginine Hydrochloride API Price is obtained through a variety of data sources. The L-Arginine Hydrochloride API Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A R-gene 10 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of R-gene 10, including repackagers and relabelers. The FDA regulates R-gene 10 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. R-gene 10 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of R-gene 10 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A R-gene 10 supplier is an individual or a company that provides R-gene 10 active pharmaceutical ingredient (API) or R-gene 10 finished formulations upon request. The R-gene 10 suppliers may include R-gene 10 API manufacturers, exporters, distributors and traders.
click here to find a list of R-gene 10 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A R-gene 10 DMF (Drug Master File) is a document detailing the whole manufacturing process of R-gene 10 active pharmaceutical ingredient (API) in detail. Different forms of R-gene 10 DMFs exist exist since differing nations have different regulations, such as R-gene 10 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A R-gene 10 DMF submitted to regulatory agencies in the US is known as a USDMF. R-gene 10 USDMF includes data on R-gene 10's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The R-gene 10 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of R-gene 10 suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The R-gene 10 Drug Master File in Japan (R-gene 10 JDMF) empowers R-gene 10 API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the R-gene 10 JDMF during the approval evaluation for pharmaceutical products. At the time of R-gene 10 JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of R-gene 10 suppliers with JDMF on PharmaCompass.
A R-gene 10 CEP of the European Pharmacopoeia monograph is often referred to as a R-gene 10 Certificate of Suitability (COS). The purpose of a R-gene 10 CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of R-gene 10 EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of R-gene 10 to their clients by showing that a R-gene 10 CEP has been issued for it. The manufacturer submits a R-gene 10 CEP (COS) as part of the market authorization procedure, and it takes on the role of a R-gene 10 CEP holder for the record. Additionally, the data presented in the R-gene 10 CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the R-gene 10 DMF.
A R-gene 10 CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. R-gene 10 CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of R-gene 10 suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing R-gene 10 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for R-gene 10 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture R-gene 10 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain R-gene 10 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a R-gene 10 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of R-gene 10 suppliers with NDC on PharmaCompass.
R-gene 10 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of R-gene 10 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right R-gene 10 GMP manufacturer or R-gene 10 GMP API supplier for your needs.
A R-gene 10 CoA (Certificate of Analysis) is a formal document that attests to R-gene 10's compliance with R-gene 10 specifications and serves as a tool for batch-level quality control.
R-gene 10 CoA mostly includes findings from lab analyses of a specific batch. For each R-gene 10 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
R-gene 10 may be tested according to a variety of international standards, such as European Pharmacopoeia (R-gene 10 EP), R-gene 10 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (R-gene 10 USP).